To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Knee OA symptoms better improved with hyaluronic acid treatment vs. 6-methylprednisolone

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2016

Knee OA symptoms better improved with hyaluronic acid treatment vs. 6-methylprednisolone

Vol: 5| Issue: 2| Number:41| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Hyaluronic Acid Versus Methylprednisolone Intra-Articularly Injected for the Treatment of Osteoarthritis of the Knee

Current Therapeutic Research. 1991 Nov;50(5):691-99

Contributing Authors:
P Pietrogrande PL Melanotte B D'agnolo M Ulivi GA Benigni L Turchetto P Pierfederici A Perbellini

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

90 patients with knee osteoarthritis were included in this trial and randomized to receive either sodium hyaluronate (NaHA) or 6-methylprednisolone acetate (6-MPA) as treatment. The study was conducted in order to compare efficacy and tolerability of the two drugs in knee OA. While pain, joint flexion, and duration of morning stiffness outcomes significantly favoured HA treatment, analgesic consum...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue